Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02749422 · ClinicalTrials.gov registry record · NA
fMRI Guided TMS Enhancement of Associative Memory Networks
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02749422 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 8 participants.
The verdict
NCT02749422, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This is a randomized, single-blinded, controlled phase 1 study to demonstrate feasibility and explore the neurophysiologic and clinical effects of repetitive transcranial magnetic stimulation (TMS) interventions in epilepsy patients and healthy controls. The inclusion of a control group will be used to see whether epilepsy patients, who suffer from a higher degree of comorbid memory difficulty presumably from entorhinal-hippocampal dysfunction, can benefit from a TMS intervention can benefit as much as a healthy matched population. Investigators will also be looking at functional connectivity between the hippocampus and cortical regions
Interventions
- DIAGNOSTIC_TEST MagStim RapidStim2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-10-14 |
| Est. Completion | 2023-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02749422
The ClinicalTrials.gov registry entry for NCT02749422 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MagStim RapidStim2 is the first listed.
NCT02749422 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02749422 about?
NCT02749422 is a clinical study titled "fMRI Guided TMS Enhancement of Associative Memory Networks". This is a randomized, single-blinded, controlled phase 1 study to demonstrate feasibility and explore the neurophysiologic and clinical effects of repetitive transcranial magnetic stimulation (TMS) interventions in epilepsy patients and healthy controls. The inclusion of a control group will be used...
What is the current status of trial NCT02749422?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2016-10-14. Estimated completion is 2023-03-30.
What interventions are being tested in trial NCT02749422?
The interventions under investigation include: MagStim RapidStim2 (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02749422?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.